TD Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $616K | Hold |
|
|||||
|
2025
Q1 | $796K | Hold |
|
|||||
|
2024
Q4 | $1.16M | Sell |
|
|||||
|
2024
Q3 | $1.97M | Sell |
|
|||||
|
2024
Q2 | $1.86M | Buy |
|
|||||
|
2024
Q1 | $1.96M | Buy |
|
|||||
|
2023
Q4 | $763K | Hold |
|
|||||
|
2023
Q3 | $754K | Buy |
|
|||||
|
2023
Q2 | $991K | Buy |
|
|||||
|
2023
Q1 | $858K | Hold |
|
|||||
|
2022
Q4 | $1.09M | Buy |
|
|||||
|
2022
Q3 | $1.7M | Buy |
|
|||||
|
2022
Q2 | $1.46M | Buy |
|
|||||
|
2022
Q1 | $1.11M | Buy |
|
|||||
|
2021
Q4 | $1.63M | Sell |
|
|||||
|
2021
Q3 | $2.86M | Buy |
|
|||||
|
2021
Q2 | $2.01M | Buy |
|
|||||
|
2021
Q1 | $2.88M | Buy |
|
|||||
|
2020
Q4 | $1.97M | Buy |
|
|||||
|
2020
Q3 | $2.93M | Sell |
|
|||||
|
2020
Q2 | $3.53M | Buy |
|
|||||
|
2020
Q1 | $1.05M | Sell |
|
|||||
|
2019
Q4 | $1.5M | Hold |
|
|||||
|
2019
Q3 | $1.58M | Hold |
|
|||||
|
2019
Q2 | $1.55M | Buy |
|
|||||
|
2019
Q1 | $741K | Buy |
|
|||||
|
2018
Q4 | $674K | Buy |
|